AUTOGRAFT
-
Biologics
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS – July 26, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Biologics
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
October 7, 2020 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus,…
Read More » -
Sports Medicine
Autografts may improve ACL reconstructions
Anterior Cruciate Ligament (ACL) reconstructions occur more than 200,000 times a year, but the type of material used to create…
Read More »